123 Main Street, New York, NY 10001
Investor Relations
Changing the Future
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.
Stock Information
Corporate Governance
Events & Webcasts
Investor AlertsFinancial Data
Stock Information
NASDAQCODX
